Suchergebnisse - "Yin, Shengxia"

PubPharm (7)

1

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA

enthalten in: Emerging microbes & infections | 2024

von Wang, J. | Zhu, L. | Zhang, S. | +19

2

Serum CXCL16 : A new predictor of liver inflammation in patients with chronic hepatitis B

enthalten in: Journal of viral hepatitis | 2024

von Wan, Y. | Mao, M. | Li, M. | +6

3

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

enthalten in: Emerging microbes & infections | 2023

von Yin, S. | Wan, Y. | Issa, R. | +13

4

Baseline albumin-bilirubin score : a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment

enthalten in: European journal of gastroenterology & hepatology | 2023

von Zhang, Y. | Gu, Y. | Yin, S. | +13

5

Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Wang, J. | Yan, X. | Zhu, L. | +21

CommentIn: Aliment Pharmacol Ther. 2023 Mar;57(5):579-580. - PMID 36786454

6

Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B

enthalten in: JAMA network open | 2022

von Wang, J. | Ding, W. | Liu, J. | +16

7

Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA

enthalten in: Journal of medical virology | 2022

von Yao, K. | Wang, J. | Wang, L. | +10

1
[1]